Isabelle Kenyon is the Founder & CEO of Calibrate, a metabolic health company on a mission to change the way the world treats weight. At Calibrate, Isabelle is pioneering a new standard of care for obesity treatment with the belief that medication is a tool—not a long-term treatment. Calibrate's proprietary intensive lifestyle intervention has three years of proven and published results to improve both weight and overall metabolic health in patients, and its continuous authorization product enables payors to take risk on expanding access to its cost-effective obesity treatment.  Prior to Calibra...read more